SAN DIEGO--(BUSINESS WIRE)--Synteract, Inc., a full-service contract research organization (CRO) dedicated to meeting the clinical research, technology, and safety needs of biotechnology, medical device, and pharmaceutical companies, has expanded its consulting offerings to include expert advice to venture capital organizations (VCs) that fund biotech, medical device, and pharmaceutical start-ups.
